BIOMARIN PHARMACEUTICAL INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Novato, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BIOMARIN PHARMACEUTICAL INC has filed 2,724 SEC EDGAR filings since 04 May 1999

SEC filing history

Showing 476-500 of 1,000 matching filings.

Per page
25
Current page
20
DEFA14A File 000-26727

DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

Filing date
13 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-26727

DEFINITIVE PROXY STATEMENT

Filing date
13 Apr 2021
Reporting date
25 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Apr 2021
Reporting date
08 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Apr 2021
Reporting date
01 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Apr 2021
Reporting date
30 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
26 Mar 2021
Reporting date
24 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Mar 2021
Reporting date
22 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Mar 2021
Reporting date
22 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Mar 2021
Reporting date
22 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Mar 2021
Reporting date
22 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Mar 2021
Reporting date
22 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Mar 2021
Reporting date
18 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2021
Reporting date
15 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Mar 2021
Reporting date
04 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Mar 2021
Reporting date
05 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56595

SCHEDULE 13G/A

Filing date
08 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Feb 2021
Reporting date
19 Feb 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .